Effects of endotoxin lipopolysaccharide administration on the somatotropic axis

Journal of Endocrinology

Volumn 159, Issue 2, 1998, Pages 239-246

  Soto, L ^a   Martin A I ^b   Millan S ^a   Vara, E ^a   Lopez Calderon A ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSIDAD EUROPEA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; ENDOTOXIN; GROWTH HORMONE; INSULIN; LIPOPOLYSACCHARIDE; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; SOMATOSTATIN;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC INFLAMMATION; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DOSE RESPONSE; GROWTH HORMONE RELEASE; IMMUNOBLOTTING; INSULIN BLOOD LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; WEIGHT REDUCTION;

EID: 0031772959     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1590239     Document Type: Article

References (44)

1. Besedovsky HO & Del Rey A 1996 Immune-neuro-endocrine interactions: facts and hypotheses. Endocrine Reviews 17 64-102.
2. Besedovsky HO, Sorkin E, Keller M & Muller J 1975 Changes in blood hormone levels during the immune response. Proceedings of the Society for Experimental Biology and Medicine 150 466-470.
3. Bundz S, Molina PE, Lang CH & Abumrad NN 1995 Endogenous opiates do not modulate LPS-induced alterations in carbohydrate metabolism. Shock 4 397-402.
4. Dahn MS, Lange P & Jacobs LA 1988 Insulin-like growth factor I production is inhibited in human sepsis. Archives Surgery 123 1409-1414.
5. Daughaday WH, Mariz IK & Blethen SL 1980 Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: a comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum. Journal of Clinical Endocrinology and Metabolism 51 781-788.
6. Egdahl RH 1959 The differential response of the adrenal cortex and medulla to bacterial endotoxin. Journal of Clinical Ivestigation 38 921-929.
7. Elsasser TH, Caperna TJ & Fayer R 1991 Tumor necrosis factor-α affects growth hormone secretion by a direct pituitary interaction. Proceedings of the Society for Experimental Biology and Medicine 198 547-554.
8. Fan J, Molina PE, Gelato MC & Lang CH 1994 Differential tissue regulation of insulin-like growth factor-I content and binding proteins after endotoxin. Endocrinology 134 1685-1692.
9. Fan J, Char D, Kolasa AJ, Pan W, Maitra SR, Patlak CS, Spolarics Z, Gelato MC & Lang CH 1995a Alterations in hepatic production and peripheral clearance of IGF-I after endotoxin. American Journal of Physiology 269 E33-E42.
10. Fan J, Char D, Bagby GJ, Gelato MC & Lang CH 1995b Regulation of insulin-like growth factor-I (IGF-I) and IGF-binding proteins by tumor necrosis factor. American Journal of Physiology 269 1204-1212.
11. Fukata J, Kastin NW & Martin JB 1985 Somatostatin release from the median eminence of unanesthetized rats: lack of correlation with pharmacologically suppressed growth hormone secretion. Neuroendocrinology 40 193-200.
12. Hadid R, Spinedi E, Daneva T, Grau G & Gaillard RC 1995 Repeated endotoxin treatment decreases immune and hypothalamo-pituitary-adrenal axis responses: effects of orchidectomy and testosterone therapy. Neuroendocrinology 62 348-355.
13. Hadid R, Spinedi E, Giovambattista A, Chautard T & Gaillard RC 1996 Decreased hypothalamo-pituitary-adrenal axis response to neuroendocrine challenge under repeated endotoxemia. Neuroimmunomodulation 3 62-68.
14. Han GR, Dohi DF, Lee HY, Rajah R, Walsh GL, Hong WK, Cohen P & Kurie JM 1997 All-trans-retinoic acid increases transforming growth factor-beta2 and insulin-like growth factor binding protein-3 expression through a retinoic acid receptor-alpha-dependent signaling pathway. Journal of Biological Chemistry 272 13711-13716
15. Hembree JR, Pampusch MS, Yang F, Causey JL, Hathaway MR & Dayton WR 1996 Cultured porcine myogenic cells produce insulin-like growth factor binding protein-3 (IGFBP-3) and transforming growth factor beta-1 stimulates IGFBP-3 production. Journal of Animal Science 74 1530-1540.
16. Hossenlop P, Seurin D, Segovia-Quinson B, Hardouin S & Binoux M 1986 Analysis of serum insulin-like growth factor binding protein using western blotting: use of the method for titration of the binding proteins and competitive binding studies. Analytical Biochemistry 154 138-143.
17. Kastin NW & Martin JB 1982 Altered release of growth hormone and thyrotropin induced by endotoxin in the rat. American Journal of Physiology 43 E332-E337.
18. Lang CH, Cooney R & Vary TC 1996 Central interleukin-1 partially mediates endotoxin-induced changes in glucose metabolism. American Journal of Physiology 271 E309-E316.
19. López-Calderón A, González-Quijano MI, Tresguerres JAF & Ariznavarreta C 1990 Role of LHRH in the gonadotropin response to restraint stress in intact male rats. Journal of Endocrinology 124 241-246.
20. McCaffery T, Khosrow N, Lawrence A & Kirsner J 1970 Severe growth retardation in children with inflammatory bowel disease. Pediatrics 45 386-393.
21. Madden KS & Felten DL 1995 Experimental basis for neural-immune interactions. Physiological Reviews 75 77-106.
22. Masuhara M 1995 Expression of hepatocyte growth factor and transforming growth factor beta 1 mRNA in P. acnes and lipopolysaccharide-treated rats. Journal of Gastroenterology 30 48-54.
23. Mefford IN, Master CF, Hepes MP & Eskay RL 1991 Cytokine-induced activation on the neuroendocrine axis persists in endotoxin-tolerant mice. Brain Research 557 327-330.
24. Mengozzi M & Ghezzi P 1991 Defective tolerance to toxic and metabolic effects of interleukin-1. Endocrinology 128 1668-1672.
25. Michalek SM, Moore RN, McGhee JR, Rosentreich DL & Mergenhagen SE 1980 The primary role of lymphoreticular cells in the mediation of host responses to bacterial endotoxin. Journal of Infectious Diseases 141 55-63.
26. Millán S, González-Quijano MI, Giordano M, Soto L, Martín AI & López-Calderón A 1996 Short and long restraint differentially affect humoral and cellular immune functions. Life Sciences 59 1431-1442.
27. Neidel J, Blum WF, Schaeffer, Schulze M, Schönau, Linschau J & Föll J 1997 Elevated levels of insulin-like growth factor (IGF) binding protein-3 in rheumatoid arthritis synovial fluid inhibit stimulation by IGF-I of articular chondrocyte proteoglycan synthesis. Rheumatology International 17 29-37.
28. Olney RC, Wilson DM, Mohtai M, Fielder PJ & Smith RL 1995 Interleukin-1 and tumor necrosis factor-α increase insulin-like growth factor-binding protein-3 (IGFBP-3) production and IGFBP-3 protease activity in human articular chondrocytes. Journal of Endocrinology 146 279-286.
29. Ooi GT, Orlowski CC, Brown AL, Becker RE, Unterman TG & Rechler MM 1990 Different tissue distribution and hormonal regulation of messenger RNAs encoding rat insulin-like growth factor-binding proteins-1 and -2. Molecular Endocrinology 4 321-328.
30. Payne LC, Obal F & Krueger JM 1992 Stimulation and inhibition of growth hormone secretion by interleukin-1 beta: the involvement of growth hormone-releasing hormone. Neuroendocrinology 56 118-123.
31. Peisen JN, McDonnell KJ, Mulroney SE & Lumpkin MD 1995 Endotoxin-induced suppression of the somatotropic axis is mediated by interleukin-1β and corticotropin-releasing factor in the juvenile rat. Endocrinology 136 3378-3390.
32. Pinchot GB, Close VP & Long CNH 1949 Adrenal changes produced in rats by infection with B. turalense and B. coli. Endocrinology 45 135-142.
33. Rettori V, Jurcovicova J & McCann SM 1987 Central action of interleukin-1 in altering the release of TSH, growth hormone and prolactin in the male rat. Journal of Neuroscience Research 18 179-183.
34. Rettori V, Milenkovic L, Beutler BA & McCann SM 1989 Hypothalamic action of cachectin to alter pituitary hormone release. Brain Research Bulletin 23 471-475.
35. Samstein B, Holmes ML, Fan J, Frost RA, Gelato MC & Lang CH 1996 IL-6 stimulation of IGFBP-1 production. Biochemical and Biophysical Research Communications 228 611-615.
36. Spagnoli A & Rosenfeld RG 1997 Insulin-like growth factor binding proteins. Current Opinion in Endocrinology and Diabetes 4 1-9.
37. Tamarit-Rodriguez J, Vara E & Tamarit J 1985 Antigenic specificity of a new and potent somatostatin antiserum. Hormone and Metabolism Research 17 623-625.
38. Thissen JP & Verniers J 1997 Inhibition by interleukin-1β and tumor necrosis factor-α of the insulin-like growth factor-I messenger ribonucleic acid response to growth hormone in rat hepatocyte culture. Endocrinology 138 1078-1084.
39. Thissen JP, Pucilowska JB & Underwood LE 1994 Differential regulation of insulin-like growth factor-I (IGF-I) and IGF binding protein-1 messenger ribonucleic acids by amino acid availability and growth hormone in rat hepatocyte primary cultures. Endocrinology 134 1570-1576.
40. Vara E & Tamarit-Rodriguez J 1988 Islet secretion of immunoreactive thyrotropin-releasing hormone and the 'paracrine-like' effects of its exogenous administration. Acta Endocrinologica 118 429-436.
41. Virkamaki A & Yki-Järvinen H 1994 Mechanism of insulin resistance during acute endotoxemia. Endocrinology 134 2072-2078.
42. Wada Y, Sato M, Niimi M, Tamaki M, Ishida T & Takahara J 1995 Inhibitory effects of interleukin-1 on growth hormone secretion in conscious male rats. Endocrinology 136 3936-3941.
43. Walton PE & Cronin MJ 1989 Tumor necrosis factor-alpha inhibits growth hormone secretion from cultured anterior pituitary cells. Endocrinology 125 925-929.
44. Yki-Järvinen H, Sammalkorpi K, Koivisto VA & Nikkilä EA 1989 Severity, duration, and mechanism of insulin resistance during acute infection. Journal of Clinical Endocrinology and Metabolism 69 317-323.